Blood News and Research

RSS

Dr Sartori’s contentious alternative therapy: inquest date set

The Medical Practitioner's Board of Western Australia is looking into the case of a doctor and her role in an alternative cancer therapy program. Five cancer patients have died after apparently being given industrial solvents and dangerous minerals as a part of an alternative therapy program by Alexandra Boyd, a well-known Mosman Park breast cancer specialist. She along with two registered nurses administered the concoctions to the people in question.

1 Nov 2010

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

The U.S. Food and Drug Administration approved the cancer drug Afinitor (everolimus) on Friday to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS), a rare genetic disorder. This approval was for treatments of SEGA that can not be treated with surgery.

1 Nov 2010

Gore announces new Early TIPS for Ascites Study

W.L. Gore & Associates (Gore) today announced a new prospective, randomized, multi-center study at the Annual Meeting of the American Association for the Study of Liver Diseases. The hypothesis of the study is that early intervention with the GORE® VIATORR® TIPS Endoprosthesis improves transplant-free survival when compared to large volume paracentesis in patients with cirrhosis and difficult to treat ascites.

1 Nov 2010

Pasteurized human breast milk recommended alternative for hospitalized sick newborns

Pasteurized human milk is a recommended alternative for hospitalized sick newborns when their own mother's milk is not available, according to a new statement by the Canadian Paediatric Society. The statement, published today in Paediatrics & Child Health, says that human milk banking in Canada should be encouraged and promoted.

1 Nov 2010

FDA grants Clinical Data's PRX-8066 Orphan Drug Designation for pulmonary arterial hypertension

Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.

1 Nov 2010

Sugar in excess leads to complications

In light of Diabetes Awareness Month, many people are showing increased interest in the topic of sugar and sugar alternatives. With the various forms of sugar available table sugar, high-fructose corn syrup, agave, and honey understanding the differences between sugars and their effects on the body is not all sweet.

1 Nov 2010

Oncimmune to present benefits of EarlyCDT-Lung cancer test at ACCP annual meeting

Oncimmune® LLC, maker of EarlyCDT-Lung, a simple blood test that aids physicians in the risk assessment and early detection of lung cancer, today announced that two oral presentations and five poster presentations during this week's American College of Chest Physicians' (ACCP) annual meeting in Vancouver will collectively highlight the clinical and economic benefits of EarlyCDT-Lung.

1 Nov 2010

Clear guidelines needed for consistent diagnosis and treatment of childhood stroke

Researchers are calling for clear guidelines on childhood stroke after a study, published in the November issue of Acta Paediatrica, found wide variations in time lag to diagnosis, investigation and treatment.

1 Nov 2010

GE Healthcare enters agreement to acquire assets of Orbotech Medical

GE Healthcare, a unit of General Electric Company announced that it has entered into an agreement to acquire the assets of Orbotech Medical Solutions Ltd., a subsidiary of Orbotech Ltd. (Orbotech), and a manufacturer of cadmium zinc telluride (CZT) detectors used in GE Healthcare's innovative Alcyone nuclear medicine technology.

1 Nov 2010

Shield signs strategic commercialization agreement for ST10-021 iron therapy product

Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that it has signed a strategic commercialisation agreement for its lead asset, ST10-021, an iron therapy product which has commenced Phase III clinical development, with AOP Orphan Pharmaceuticals AG.

1 Nov 2010

Medivir's partner Tibotec reports Week 24 interim results from TMC435 Phase 2b study in HCV

Medivir AB, the research-based speciality pharmaceutical company focused on the development of high-value treatments for infectious diseases, notes that its development partner, Tibotec Pharmaceuticals, has announced the results of a Week-24 planned interim analysis of the Phase 2 response-guided PILLAR study for TMC435, Medivir's key pipeline asset, a hepatitis C protease inhibitor dosed once-daily.

1 Nov 2010

Consumption of peanut during pregnancy may increase risk of allergy in infants: Study

Researchers have found that allergic infants may be at increased risk of peanut allergy if their mothers ingested peanuts during pregnancy. The data are reported in the November 1, 2010 issue of the Journal of Allergy and Clinical Immunology.

1 Nov 2010

New laboratory-engineered livers could provide solution to donor shortage

Researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have reached an early, but important, milestone in the quest to grow replacement livers in the lab. They are the first to use human liver cells to successfully engineer miniature livers that function - at least in a laboratory setting like human livers. The next step is to see if the livers will continue to function after transplantation in an animal model.

1 Nov 2010

Tibotec to present Week-24 interim analysis of PILLAR study for chronic HCV treatment at AASLD Meeting

Tibotec Pharmaceuticals announced today the company will present the results of a Week-24 planned interim analysis of the phase 2 response-guided PILLAR study in treatment-naive patients with chronic genotype 1 hepatitis C virus (HCV) at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston, MA., USA. The data will be presented as part of a late-breaker oral presentation on Monday, November 1.

1 Nov 2010

Gilead to present data of two Phase III trials evaluating Viread efficacy for HBV infection at The Liver Meeting 2010

Gilead Sciences, Inc. today announced new data from the open-label phase of two pivotal Phase III clinical trials (Studies 102 and 103) evaluating the four-year efficacy of Viread (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B virus (HBV) infection.

1 Nov 2010

‘Off the shelf’ new livers from stem cells, glimmer of hope

A researcher team has successfully produced a small-scale version of a human liver in the laboratory using stem cells. This could be a boon for patients waiting for liver transplants although it will take years to perfect the procedure say researchers.

31 Oct 2010

HDMG and Heritage Health Care host over 4000 seniors at 20th anniversary of Health Expo

Dr. Richard Merkin, High Desert Medical Group and Heritage Health Care hosted over four thousand seniors at their 20th anniversary annual Senior Expo at the Antelope Valley Fairgrounds. Seniors lined up prior to the 9:00 am start, eager to see celebrity Debbie Reynolds perform and get free health screenings and testing including bone density, cholesterol, glucose, blood pressure, body fat, dental and vision screenings and of course, seasonal flu shots.

30 Oct 2010

Presidio to present PPI-461 data for HCV infection at AASLD meeting

Presidio Pharmaceuticals, Inc. announced today that Nathaniel Brown, M.D., Chief Medical Officer, will present a late-breaker poster, "Safety and Pharmacokinetics of PPI-461, a Potent New Hepatitis C virus (HCV) NS5A Inhibitor with Pan-Genotype Activity" at the 61st AASLD meeting in Boston, MA, on November 1, 2010.

30 Oct 2010

NYBC calls for blood donations during Pancreatic and Lung Cancer Awareness Month

November is Pancreatic Cancer Awareness Month and Lung Cancer Awareness Month, and New York Blood Center (NYBC) serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon our communities to please join the fight against cancer by donating blood. Healthy people of all blood types and ethnicities are encouraged to donate and help save lives. Blood donations are particularly needed from O-negative, B-negative and A-negative types.

30 Oct 2010

Physicians suggest patients who receive MoM hip replacement to pay attention on post-operative pain

Total hip arthroplasty (THA) is one of the most successful surgeries of the past several decades. This procedure has relieved pain and restored movement to hundreds of thousands of people. The decision to have hip replacement surgery should be only made after discussion between the patient and his or her orthopaedic surgeon.

30 Oct 2010

Blood News and Research

Dr Sartori’s contentious alternative therapy: inquest date set

FDA approves cancer drug Afinitor for treatment of rare genetic disorder

Gore announces new Early TIPS for Ascites Study

Pasteurized human breast milk recommended alternative for hospitalized sick newborns

FDA grants Clinical Data's PRX-8066 Orphan Drug Designation for pulmonary arterial hypertension

Sugar in excess leads to complications

Oncimmune to present benefits of EarlyCDT-Lung cancer test at ACCP annual meeting

Clear guidelines needed for consistent diagnosis and treatment of childhood stroke

GE Healthcare enters agreement to acquire assets of Orbotech Medical

Shield signs strategic commercialization agreement for ST10-021 iron therapy product

Medivir's partner Tibotec reports Week 24 interim results from TMC435 Phase 2b study in HCV

Consumption of peanut during pregnancy may increase risk of allergy in infants: Study

New laboratory-engineered livers could provide solution to donor shortage

Tibotec to present Week-24 interim analysis of PILLAR study for chronic HCV treatment at AASLD Meeting

Gilead to present data of two Phase III trials evaluating Viread efficacy for HBV infection at The Liver Meeting 2010

‘Off the shelf’ new livers from stem cells, glimmer of hope

HDMG and Heritage Health Care host over 4000 seniors at 20th anniversary of Health Expo

Presidio to present PPI-461 data for HCV infection at AASLD meeting

NYBC calls for blood donations during Pancreatic and Lung Cancer Awareness Month

Physicians suggest patients who receive MoM hip replacement to pay attention on post-operative pain

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News